Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients

This study has been completed.
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00229346
First received: September 28, 2005
Last updated: December 18, 2007
Last verified: December 2007
  Purpose

Assessing FM and psychiatric disorder in patients suffering from PMS or PMDD


Condition
Premenstrual Syndrome

Study Type: Observational
Study Design: Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Study Start Date: October 2004
Estimated Study Completion Date: January 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • PMDD
  • PMS
  • Referral to gynecologist clinic without symptoms of PMS or PMDD
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00229346

Locations
Israel
Chaim Sheba Medical Center
Ramat-Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Joseph Zohar, MD Tel Aviv University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00229346     History of Changes
Other Study ID Numbers: SHEBA-04-3457-JZ-CTIL
Study First Received: September 28, 2005
Last Updated: December 18, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Premenstrual Syndrome
Menstruation Disturbances
Pathologic Processes

ClinicalTrials.gov processed this record on September 30, 2014